Table 1 (abstract P194). Study results

Patients

12 (100)

Age at baseline, median (range), years

25.3 (1.4-54.9)

Disease duration, median (range), years

15.5 (1.4-51.3)

Anakinra dose at baseline, median (range), mg/kg/day

1.7 (1.1-2.5)

Total duration of anakinra exposure, median (range), years

1.3 (0.5-7)

Patients with AEs

1 (8.3)

Any AE

7 (100)

Urinary tract infection

1 (14.3)

Upper respiratory tract infection

1 (14.3)

Tonsillitis

5 (71.4)